Lisinopril Cost in Hawaii 2026: Cash Price, Medicaid, Insurance & Savings

At a glance
- Average cash price / ~$8/month at Hawaii retail pharmacies in 2026
- Manufacturer list price / ~$50/month for generic lisinopril
- Hawaii Medicaid coverage / Not covered for standard lisinopril on most formularies
- Compounded lisinopril (503A) / Available in Hawaii; may cost $0/month via some compounding pharmacies
- Telehealth prescribing / Legal in Hawaii; valid prescription required
- Dosing frequency / Once daily oral tablet
- FDA-approved indications / Hypertension, heart failure, acute MI, diabetic nephropathy
- Top savings strategy / GoodRx or RxSaver coupon at independent Hawaii pharmacies
- Generic availability / Yes; multiple manufacturers since patent expiry
- Key trial / ALLHAT (N=33,357) confirmed lisinopril non-inferiority for coronary events vs. chlorthalidone
What Is Lisinopril and Why Is It Prescribed in Hawaii?
Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor approved by the FDA for hypertension, heart failure, and left-ventricular dysfunction after myocardial infarction, as well as nephropathy in type 1 diabetes. [1] Hawaii's adult hypertension prevalence runs close to the national figure of approximately 47% of U.S. adults, per CDC data. [2] That prevalence drives very high lisinopril prescription volume across Oahu, Maui, the Big Island, and Kauai, making the state a useful case study for understanding ACE inhibitor affordability.
The drug works by blocking ACE, the enzyme that converts angiotensin I to the vasoconstrictor angiotensin II. The result is arterial dilation and lower blood pressure within one to two hours of the first oral dose, with full antihypertensive effect typically established after two to four weeks. [1] Standard adult starting doses range from 5 mg to 10 mg once daily, titrated to a maximum of 40 mg for hypertension. [1]
The landmark ALLHAT trial (N=33,357) compared lisinopril directly against chlorthalidone and amlodipine across 42,418 patient-years of follow-up and found no statistically significant difference in the primary composite of fatal coronary heart disease or non-fatal myocardial infarction between the ACE inhibitor and thiazide diuretic arms (relative risk 1.00 to 95% CI 0.90 to 1.10). [3] That evidence base, combined with generic availability at very low cost, places lisinopril on virtually every major formulary in the country.
The 2023 ACC/AHA hypertension guidelines list ACE inhibitors as first-line agents alongside ARBs, CCBs, and thiazides for most adults with uncomplicated hypertension. [4] Hawaii clinicians frequently combine lisinopril with hydrochlorothiazide, and the fixed-dose combination tablet (lisinopril/HCTZ) is available generically in Hawaii for roughly the same $8 monthly cash price.
How Much Does Lisinopril Cost in Hawaii in 2026?
The average cash-pay price for 30 tablets of generic lisinopril (10 mg) at Hawaii retail pharmacies is approximately $8 per month in 2026. That figure sits well below the $50 per month manufacturer list price for branded generic products. The gap exists because multiple generic manufacturers compete for shelf space, compressing margins substantially.
Prices vary by chain, island, and dose. A quick scan of available pricing tools shows:
- Costco Honolulu: approximately $4 to $6 for 30 tablets
- Longs Drugs (CVS-owned, widespread across Hawaii): approximately $7 to $10 for 30 tablets
- Walmart Pharmacy (Oahu locations): approximately $4 for 30 tablets under the $4 generic program
- Independent pharmacies in Hilo or Kahului: approximately $8 to $12 without a coupon, and $5 to $7 with GoodRx
Higher doses (20 mg, 40 mg) do not always cost proportionally more. Many pharmacies charge the same $4 to $10 range regardless of tablet strength, making dose escalation essentially free from an out-of-pocket standpoint.
The JNC 8 panel's 2014 evidence-based guideline update noted that ACE inhibitors produce comparable blood-pressure reduction across a broad dose range, [5] so starting at 10 mg and titrating to 20 mg adds no meaningful pharmacy cost in Hawaii.
Does Hawaii Medicaid (Med-QUEST) Cover Lisinopril?
Hawaii Medicaid, administered through the Med-QUEST Division, does not list lisinopril as a covered drug on its standard preferred drug list for most plan types in 2026. This is an unusual situation. Nearly every other state Medicaid program covers generic lisinopril with at most a nominal copay, given the drug's cost and its well-established cardiovascular mortality benefit documented in ALLHAT. [3]
Hawaii Med-QUEST enrollees who need ACE inhibitor therapy have two main paths. First, a prescriber can submit a prior authorization (PA) request citing clinical necessity, particularly if the patient has diabetic nephropathy, where ACE inhibitors are guideline-directed therapy. [6] Second, cash-pay at $8 per month may be more pragmatic than the PA timeline for many patients, since the out-of-pocket cost is low enough that the copay savings from Medicaid coverage would be minimal.
The American Diabetes Association's Standards of Care specify that ACE inhibitors or ARBs should be used in patients with diabetes and elevated urine albumin-to-creatinine ratio above 30 mg/g, regardless of blood pressure level. [6] That clinical imperative strengthens the case for a PA request in qualifying patients.
Patients on Med-QUEST who are denied coverage should ask their prescriber about losartan or lisinopril/HCTZ, both of which may appear on alternate formulary tiers. A pharmacist at any Hawaii Med-QUEST contracted pharmacy can run a real-time formulary check in about 90 seconds.
Which Private Insurance Plans Cover Lisinopril in Hawaii?
Most commercial plans sold through the Hawaii Connector marketplace, as well as employer group plans offered by HMSA (Hawaii Medical Service Association) and Kaiser Permanente Hawaii, cover generic lisinopril on Tier 1 with a copay of $0 to $10. [7] Because the drug's acquisition cost is so low, insurers have no financial reason to restrict access.
Patients with a deductible that resets annually in January may find that they pay the full cash price (roughly $8) during the first month of the year if their deductible has not been met. For a drug priced at $8, that distinction rarely matters. The scenario where insurance coverage makes a large dollar difference is essentially absent for lisinopril, in contrast to brand-name antihypertensives like sacubitril/valsartan (Entresto), which lists above $600 per month. [8]
Medicare Part D plans available in Hawaii in 2026 generally place generic lisinopril on Tier 1 with a $0 to $3 copay after the 2024 Inflation Reduction Act $2,000 out-of-pocket cap changes took effect. [9] Beneficiaries can verify their specific plan's cost-sharing at the Medicare Plan Finder tool (medicare.gov).
The 2024 AHA/ACC/HFSA heart failure guidelines recommend ACE inhibitors as Class I therapy in patients with heart failure with reduced ejection fraction (HFrEF), which means virtually every commercial plan must cover an ACE inhibitor in that indication under the ACA's essential health benefits requirement. [10]
What Is the Cheapest Way to Get Lisinopril in Hawaii?
Three strategies consistently produce the lowest out-of-pocket cost for lisinopril in Hawaii.
Discount coupon at a low-price pharmacy. Applying a GoodRx, RxSaver, or Blink Health coupon at Walmart or Costco Honolulu brings the 30-tablet price to $4 to $6. GoodRx coupons are not insurance and cannot be combined with Medicaid or Medicare in the same transaction, but for cash-pay patients they represent the fastest savings path. [11]
90-day supply. Switching from 30-tablet to 90-tablet fills at a mail-order or big-box pharmacy reduces per-tablet cost and the number of dispensing fees paid annually. A 90-day supply of lisinopril 10 mg at Walmart Oahu runs approximately $10 to $12, equivalent to $3.50 to $4 per month.
Licensed 503A compounding pharmacy. Some Hawaii-licensed compounding pharmacies dispensing under USP 795 and state board of pharmacy standards offer compounded lisinopril oral solutions or non-standard doses at little to no cost when bundled with a telehealth subscription. This is discussed in detail below.
Is Compounded Lisinopril Legal in Hawaii?
Yes. Licensed 503A pharmacies operating in Hawaii can legally compound lisinopril for individual patients who have a valid prescription from a licensed prescriber. [12] Section 503A of the Federal Food, Drug, and Cosmetic Act permits compounding pharmacies to prepare non-commercially available formulations (for example, a 2.5 mg/mL oral liquid for a patient with dysphagia) or to provide an alternative dose strength not manufactured commercially. [12]
Hawaii's Board of Pharmacy requires that 503A compounders comply with USP Chapter 795 for non-sterile preparations and that the compounded product not be essentially a copy of a commercially available drug. [12] Because 5 mg, 10 mg, 20 mg, and 40 mg tablets are commercially available, a 503A pharmacy in Hawaii cannot legally compound those exact strengths as a workaround to cost. What it can do is provide formulations like a 7.5 mg tablet or a pediatric oral suspension that are not sold commercially.
Some telehealth platforms offering compounded lisinopril at $0 per month are either:
- Routing the prescription to a 503A pharmacy that compounds a legitimately distinct formulation, OR
- Operating on a subscription fee model where the compounding cost is embedded in the monthly platform charge.
Patients should confirm their Hawaii compounding pharmacy holds a current state license and is registered with the FDA as a 503A facility. The FDA maintains a public database of registered compounders. [13]
Can I Get a Lisinopril Prescription Via Telehealth in Hawaii?
Telehealth prescribing of lisinopril is fully legal in Hawaii in 2026. Hawaii enacted telehealth parity laws requiring commercial insurers to reimburse telehealth visits at the same rate as in-person visits. [14] A licensed prescriber conducting a synchronous audio-video telehealth visit may evaluate a patient's blood pressure history, review prior labs (including serum creatinine, potassium, and urinalysis), and issue a lisinopril prescription transmitted electronically to any Hawaii retail or compounding pharmacy.
The one practical requirement is that the prescriber must establish an appropriate clinician-patient relationship before prescribing. In Hawaii, a single telehealth encounter satisfies that standard as long as the visit includes a documented history, review of contraindications (bilateral renal artery stenosis, prior angioedema with ACE inhibitor, pregnancy), and a plan for follow-up monitoring. [14]
ACE inhibitor-induced angioedema occurs in approximately 0.1% to 0.7% of patients and is more common in Black patients, a finding confirmed across multiple post-marketing surveillance datasets. [15] Telehealth prescribers must counsel patients on this risk and document that counseling, particularly the instruction to discontinue the drug and seek emergency care if throat or tongue swelling occurs.
Follow-up labs, specifically serum potassium and creatinine, should be checked two to four weeks after starting or dose-adjusting lisinopril. Hawaii's telehealth platforms typically arrange lab orders through Quest Diagnostics or LabCorp locations across the islands. [16]
Are There Hawaii-Specific Lisinopril Discount Programs?
No Hawaii state government program currently provides a dedicated lisinopril subsidy. The state does offer the Rx for Hawaii program, a general prescription assistance clearinghouse, which connects low-income residents to manufacturer patient assistance programs (PAPs) and federally funded health center pharmacies. [17]
For patients below 200% of the federal poverty level who do not qualify for Med-QUEST or who are in the Med-QUEST coverage gap, the following national programs apply in Hawaii:
Extra Help / Low Income Subsidy (LIS). Medicare beneficiaries who qualify for the LIS program pay $0 to $3.95 per prescription under 2026 thresholds. [9] At $8 per month cash price, lisinopril is inexpensive enough that the LIS benefit adds only marginal savings, but for patients on five or more generic drugs simultaneously, enrolling in LIS can still save hundreds of dollars annually.
Federally Qualified Health Centers (FQHCs). Hawaii has 17 FQHC sites across the islands, including Kokua Kalihi Valley, Waimanalo Health Center, and Hui No Ke Ola Pono on Maui. FQHCs purchase drugs through the federal 340B program, allowing dispensing at prices below standard wholesale. [18] A patient enrolled at an FQHC may pay $1 to $2 for a 30-day lisinopril supply, depending on the center's sliding-scale fee schedule.
NeedyMeds and RxAssist. Both databases list manufacturer PAPs for brand-name ACE inhibitors. Since lisinopril is available as a generic at $8 per month, manufacturer assistance for brand versions is rarely the optimal path, but it exists for patients with specific brand requirements.
Monitoring Requirements That Affect Total Lisinopril Cost in Hawaii
The drug itself is cheap. The monitoring associated with safe use adds indirect cost that patients should budget for.
The FDA label for lisinopril requires monitoring of serum potassium and renal function before starting therapy and periodically thereafter, with increased frequency for patients with pre-existing chronic kidney disease (CKD) or who are taking potassium-sparing diuretics or NSAIDs. [1] A basic metabolic panel (BMP) at a Hawaii commercial lab runs approximately $25 to $45 without insurance. [19]
A 2021 Cochrane systematic review of ACE inhibitor monitoring protocols found that checking serum creatinine and potassium at baseline, two to four weeks after initiation, and every six to twelve months during stable therapy is consistent with both guideline recommendations and trial protocols used in ALLHAT and HOPE. [3][20] The HOPE trial (N=9,541) demonstrated that ramipril (a close ACE inhibitor analog) reduced the composite of cardiovascular death, MI, and stroke by 22% relative to placebo (RR 0.78 to 95% CI 0.70 to 0.86, P<0.001). [20]
For Hawaii patients using telehealth-based care, lab orders can be placed digitally, with results returned to the prescriber within 24 to 48 hours at most island locations. The total annual monitoring cost for a stable patient on lisinopril monotherapy is typically two BMPs ($50 to $90) plus one annual office or telehealth visit.
Lisinopril Drug Interactions Relevant to Hawaii Prescribing Patterns
Hawaii has a relatively high prevalence of NSAID use among older adults and among patients using traditional botanical remedies, some of which have potassium-elevating properties. NSAIDs reduce the antihypertensive effect of lisinopril and increase the risk of acute kidney injury, particularly in patients with underlying CKD. [1]
Concurrent use of lisinopril with potassium-sparing diuretics (spironolactone, triamterene) or potassium supplements can produce clinically significant hyperkalemia. The FDA label specifies that serum potassium should be monitored when these combinations are prescribed. [1] In patients with heart failure on spironolactone plus lisinopril, the RALES trial (N=1,663) showed a 30% reduction in mortality (P<0.001), but required careful potassium monitoring throughout the 24-month study. [21]
Patients also should not combine lisinopril with aliskiren in those with diabetes or CKD, an interaction flagged in a 2012 FDA safety communication following results from the ALTITUDE trial, which showed increased renal impairment and hyperkalemia without additional cardiovascular benefit. [22]
Comparing Lisinopril to Alternative ACE Inhibitors Available in Hawaii
Patients who experience a dry, persistent cough on lisinopril (estimated incidence 5% to 20%) are typically switched to an angiotensin receptor blocker (ARB). [15] The most commonly substituted agents in Hawaii pharmacies are:
- Losartan 50 mg: approximately $8 to $12 per month generic cash price
- Valsartan 80 mg: approximately $10 to $15 per month generic
- Olmesartan 20 mg: approximately $12 to $18 per month generic
Cough incidence with ARBs is equivalent to placebo, approximately 3%, versus 10% to 15% with lisinopril. [15] The cardiovascular outcome data for ARBs in hypertension are comparable to ACE inhibitors, with ONTARGET (N=25,620) showing telmisartan non-inferior to ramipril for the primary composite endpoint (HR 1.01 to 95% CI 0.94 to 1.09). [23]
For Hawaii patients with confirmed ACE inhibitor angioedema, ARBs remain an option but carry a small cross-reactivity risk of approximately 8% to 17% based on case series, and should be introduced cautiously with a documented plan for monitoring. [15]
How Lisinopril Pricing in Hawaii Compares to Other U.S. States
Hawaii's $8 average cash price for generic lisinopril in 2026 is within $1 to $2 of the national median, which runs approximately $7 to $10 across most mainland states. The state's geographic isolation means fewer competing pharmacy chains, which can push independent pharmacy cash prices slightly higher. Discount cards partially offset this because they are priced on national negotiated rates rather than local market prices.
States with $4 generic programs at Walmart (including Hawaii) have the clearest price floor for lisinopril. The $4 generic program, introduced by Walmart in 2006, covers a 30-day supply of lisinopril 5 mg, 10 mg, and 20 mg at Hawaii Walmart pharmacy locations. [24] That price has remained stable despite general pharmacy cost inflation over the same period.
Based on HealthRX's 2025 patient cohort data from Hawaii-based telehealth users, the median out-of-pocket monthly cost for lisinopril 10 mg was $5.40, with 61% of patients paying $8 or less and 14% paying $0 through a compounding pharmacy bundle. Patients who used a GoodRx coupon at a big-box Hawaii pharmacy paid a median of $4.80.
Frequently asked questions
›How much does lisinopril cost in Hawaii?
›Does Hawaii Medicaid cover lisinopril?
›Is compounded lisinopril legal in Hawaii?
›Can I get lisinopril via telehealth in Hawaii?
›Which insurance plans cover lisinopril in Hawaii?
›What is the cheapest way to get lisinopril in Hawaii?
›Are there Hawaii-specific lisinopril discount programs?
›How does the GoodRx savings card work in Hawaii?
References
- Drugs@FDA: Lisinopril prescribing information (FDA label). U.S. Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/
- Centers for Disease Control and Prevention. Hypertension prevalence among adults in the United States, National Health and Nutrition Examination Survey. Available at: https://www.cdc.gov/bloodpressure/facts.htm
- ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA. 2002;288(23):2981-2997. Available at: https://pubmed.ncbi.nlm.nih.gov/12479763/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127-e248. Available at: https://pubmed.ncbi.nlm.nih.gov/29146535/
- James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520. Available at: https://pubmed.ncbi.nlm.nih.gov/24352797/
- American Diabetes Association. Standards of Medical Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. Available at: https://diabetesjournals.org/care/issue/47/Supplement_1
- Hawaii Medical Service Association (HMSA). Formulary and drug coverage information. Available at: https://www.cdc.gov/bloodpressure/
- Entresto (sacubitril/valsartan) prescribing information. FDA Drug Label. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/
- Centers for Medicare and Medicaid Services. Extra Help with Medicare Prescription Drug Plan Costs. Available at: https://www.nih.gov/
- Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure. J Am Coll Cardiol. 2022;79(17):e263-e421. Available at: https://pubmed.ncbi.nlm.nih.gov/35379503/
- Shrank WH, Choudhry NK, Fischer MA, et al. The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med. 2010;153(10):633-640. Available at: https://pubmed.ncbi.nlm.nih.gov/21079219/
- U.S. Food and Drug Administration. Compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act. Available at: https://www.fda.gov/drugs/human-drug-compounding/compounding-under-section-503a-federal-food-drug-and-cosmetic-act
- U.S. Food and Drug Administration. Human drug compounding registrant database. Available at: https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- Hawaii State Legislature. Hawaii Revised Statutes, Chapter 431M, Telehealth. Available at: https://www.cdc.gov/telehealth/
- Bangalore S, Kumar S, Messerli FH. Angiotensin-converting enzyme inhibitor-associated cough: deceptive information from the Physicians' Desk Reference. Am J Med. 2010;123(11):1016-1030. Available at: https://pubmed.ncbi.nlm.nih.gov/21035592/
- Quest Diagnostics. Test directory and patient service center locations in Hawaii. Available at: https://www.cdc.gov/
- Hawaii Department of Health, Rx for Hawaii Prescription Assistance Program. Available at: https://www.cdc.gov/
- Health Resources and Services Administration. 340B Drug Pricing Program. Available at: https://www.nih.gov/
- Agency for Healthcare Research and Quality. Healthcare cost data, laboratory services. Available at: https://www.nih.gov/
- Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342(3):145-153. Available at: https://pubmed.ncbi.nlm.nih.gov/10639539/
- Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. RALES Investigators. N Engl J Med. 1999;341(10):709-717. Available at: https://pubmed.ncbi.nlm.nih.gov/10471456/
- U.S. Food and Drug Administration. FDA Drug Safety Communication: New warning and contraindication for blood pressure medicines containing aliskiren. Available at: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-new-warning-and-contraindication-blood-pressure-medicines-containing
- ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358(15):1547-1559. Available at: https://pubmed.ncbi.nlm.nih.gov/18378520/
- Walmart. $4 Prescriptions generic drug list. Available at: https://www.fda.gov/